标题
Ovarian cancer: Current status and strategies for improving therapeutic outcomes
作者
关键词
-
出版物
Cancer Medicine
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-09-28
DOI
10.1002/cam4.2560
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ad5NULL-A20: A Tropism-Modified, αvβ6 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer Therapies
- (2018) Hanni Uusi-Kerttula et al. CLINICAL CANCER RESEARCH
- Screening for Ovarian Cancer
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses
- (2018) F. Moro et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Platinum based chemotherapy selects for PDGFRα dependent angiogenesis.
- (2018) Nuala McCabe et al. JOURNAL OF CLINICAL ONCOLOGY
- Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
- (2018) Curtis McCloskey et al. Cancers
- The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
- (2018) Galaxia Rodriguez et al. Cancers
- Detection of N-glycolylneuraminic acid biomarkers in sera from patients with ovarian cancer using an engineered N-glycolylneuraminic acid-specific lectin SubB2M
- (2018) L.K. Shewell et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A brief review of the management of platinum-resistant–platinum-refractory ovarian cancer
- (2017) Bryan Oronsky et al. MEDICAL ONCOLOGY
- EMT: Present and future in clinical oncology
- (2017) Patricia G. Santamaria et al. Molecular Oncology
- Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines
- (2017) Jason Lohmueller et al. PHARMACOLOGY & THERAPEUTICS
- OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution
- (2017) Irene Kuhn et al. Molecular Therapy-Oncolytics
- Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines
- (2016) Radosław Januchowski et al. Journal of Ovarian Research
- c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma
- (2016) Ha-Jeong Kim et al. Scientific Reports
- Tumor infiltrating lymphocytes in ovarian cancer
- (2015) Phillip P Santoiemma et al. CANCER BIOLOGY & THERAPY
- VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection
- (2015) Rozanne Arulanandam et al. CANCER CELL
- Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer
- (2015) Alexi A. Wright et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
- (2015) Devansu Tewari et al. JOURNAL OF CLINICAL ONCOLOGY
- Small-molecule inhibitor of Bcl-2 (TW-37) suppresses growth and enhances cisplatin-induced apoptosis in ovarian cancer cells
- (2015) Haixia Wang et al. Journal of Ovarian Research
- MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
- (2014) Mildred Felder et al. Molecular Cancer
- Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis
- (2013) Elisabetta Bandiera et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Understanding and overcoming chemoresistance in ovarian cancer: emerging role of the endothelin axis
- (2012) A. Bagnato et al. Current Oncology
- Poly (ADP-ribose) polymerase inhibitors
- (2012) Elena S. Ratner et al. CURRENT OPINION IN ONCOLOGY
- Oncolytic Viruses to Treat Ovarian Cancer Patients - a Review of Results From Clinical Trials
- (2012) A. Hartkopf et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer
- (2012) Lana E Kandalaft et al. Journal of Translational Medicine
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary Human Ovarian Epithelial Cancer Cells Broadly Express HER2 at Immunologically-Detectable Levels
- (2012) Evripidis Lanitis et al. PLoS One
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- MDM2 antagonist nutlin-3a reverses mitoxantrone resistance by inhibiting breast cancer resistance protein mediated drug transport
- (2011) Fan Zhang et al. BIOCHEMICAL PHARMACOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- BCL2A1: the underdog in the BCL2 family
- (2011) M Vogler CELL DEATH AND DIFFERENTIATION
- Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells
- (2011) L. Rosano et al. CLINICAL CANCER RESEARCH
- Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer
- (2011) Edward J. Tanner et al. GYNECOLOGIC ONCOLOGY
- MET Signaling Pathway: A Rational Target for Cancer Therapy
- (2011) Leonard J. Appleman JOURNAL OF CLINICAL ONCOLOGY
- Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer
- (2011) Francesca De Bacco et al. JNCI-Journal of the National Cancer Institute
- Multidrug resistance associated proteins in multidrug resistance
- (2011) Kamlesh Sodani et al. Chinese Journal of Cancer
- Identification of Hypermethylated Genes Associated with Cisplatin Resistance in Human Cancers
- (2010) Xiaofei Chang et al. CANCER RESEARCH
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Successful Eradication of Established Peritoneal Ovarian Tumors in SCID-Beige Mice following Adoptive Transfer of T Cells Genetically Targeted to the MUC16 Antigen
- (2010) A. A. Chekmasova et al. CLINICAL CANCER RESEARCH
- Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients
- (2010) M. J. Besser et al. CLINICAL CANCER RESEARCH
- Ovarian cancer creates a suppressive microenvironment to escape immune elimination
- (2010) Refika Yigit et al. GYNECOLOGIC ONCOLOGY
- Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
- (2010) S. B. Howell et al. MOLECULAR PHARMACOLOGY
- Pegylated liposomal doxorubicin (CAELYX®) in patients with advanced ovarian cancer: results of a German multicenter observational study
- (2009) Jalid Sehouli et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis
- (2009) C. E. Holmes et al. CLINICAL & EXPERIMENTAL METASTASIS
- Adoptive cell therapy for the treatment of patients with metastatic melanoma
- (2009) Steven A Rosenberg et al. CURRENT OPINION IN IMMUNOLOGY
- The promise and potential pitfalls of chimeric antigen receptors
- (2009) Michel Sadelain et al. CURRENT OPINION IN IMMUNOLOGY
- Ovarian cancer tumor infiltrating T-regulatory (Treg) cells are associated with a metastatic phenotype
- (2009) Jason C. Barnett et al. GYNECOLOGIC ONCOLOGY
- Screening for Ovarian Cancer
- (2009) Daniel L. Clarke-Pearson NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic significance of c-Met expression in glioblastomas
- (2008) Doo-Sik Kong et al. CANCER
- Expanding Circle of Inhibition: Small-Molecule Inhibitors of Bcl-2 as Anticancer Cell and Antiangiogenic Agents
- (2008) Benjamin D. Zeitlin et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer
- (2008) Gabriella Ferrandina et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started